- Home
- ORIC vs SLRC Comparison
ORIC vs SLRC Comparison
Compare ORIC & SLRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ORIC | SLRC |
|---|---|---|
| Founded | 2014 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 783.0M | 771.9M |
| IPO Year | 2020 | 2010 |
Fundamental Metrics
Financial Performance| Metric | ORIC | SLRC |
|---|---|---|
| Price | $8.25 | $15.44 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 7 |
| Target Price | ★ $19.50 | $16.04 |
| AVG Volume (30 Days) | ★ 1.4M | 260.4K |
| Earning Date | 11-13-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 10.62% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.65 |
| Revenue | N/A | ★ $219,666,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $9.35 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.90 | $13.64 |
| 52 Week High | $14.93 | $17.94 |
Technical Indicators
Market Signals| Indicator | ORIC | SLRC |
|---|---|---|
| Relative Strength Index (RSI) | 27.80 | 46.97 |
| Support Level | $7.98 | $15.01 |
| Resistance Level | $8.62 | $15.64 |
| Average True Range (ATR) | 0.59 | 0.21 |
| MACD | -0.07 | -0.07 |
| Stochastic Oscillator | 6.52 | 37.08 |
Price Performance
Historical ComparisonAbout ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About SLRC SLR Investment Corp.
SLR Investment Corp is a closed-end externally managed, non-diversified management investment company that has elected to be treated as a business development company. It provides U.S. middle market businesses and intermediaries with bespoke debt financing solutions to fund working capital, acquisition, refinancing and growth capital requirements. It invests majorly in leveraged middle-market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities.